Equities

Airsculpt Technologies Inc

AIRS:NMQ

Airsculpt Technologies Inc

Actions
Health CareHealth Care Providers
  • Price (USD)3.93
  • Today's Change-0.03 / -0.76%
  • Shares traded55.39k
  • 1 Year change-51.84%
  • Beta--
Data delayed at least 15 minutes, as of Jul 05 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AirSculpt Technologies, Inc., through its wholly owned subsidiaries, is a provider of practice management services to professional associations (PAs) located throughout the United States, Canada, and the United Kingdom. The Company owns and operates non-clinical assets and provides its management services to the PAs through management services agreements (MSAs). Its direct medical procedure services segment. The Company offers fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. Its AirSculpt + procedure permanently removes fat and tightens the skin with unparalleled precision and finesse.

  • Revenue in USD (TTM)197.72m
  • Net income in USD1.56m
  • Incorporated2021
  • Employees346.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zomedica Corp25.97m-37.31m142.39m144.00--0.614--5.48-0.0381-0.03810.02650.23660.09922.1413.17180,319.40-14.26-14.03-14.73-14.4567.78---143.67-220.9810.87--0.00--33.05---102.93--89.85--
DLH Holdings Corp402.59m3.07m152.29m3.20k54.301.437.530.37830.1970.19727.687.501.17--6.57125,807.800.89245.381.117.2020.9220.560.76313.41--1.500.60690.00-4.8823.05-93.73-28.16-0.903--
Longduoduo Co Ltd8.78m1.77m159.63m--90.08401.0577.0318.190.05910.05910.29230.01335.06453.60134.94--114.14------95.04--22.55--1.04--0.00--17.93--99.48------
Biodesix Inc54.85m-47.06m183.50m217.00------3.35-0.5465-0.54650.6308-0.05660.653--7.42252,760.40-56.02-55.60-82.08-80.9476.2759.53-85.80-105.15---3.711.18--28.4619.1620.32--106.31--
Joint Corp119.12m-11.13m199.75m444.00--7.61--1.68-0.7556-0.75568.041.751.29--35.08268,283.10-12.014.32-17.556.0590.9490.28-9.343.68--1,198.660.0022--16.2426.27-1,656.09--35.09--
23andMe Holding Co.219.64m-666.70m208.36m560.00--1.10--0.9487-1.39-1.390.46150.38460.328410.5984.14392,210.70-99.67---125.67--45.2546.35-303.55-121.631.91--0.00---26.66-13.01-113.92---19.09--
Airsculpt Technologies Inc197.72m1.56m227.98m346.00164.042.7318.521.150.02410.02413.431.450.9593--136.64571,456.600.7588--0.8478--65.54--0.791----4.020.4602--16.07--69.49------
Viemed Healthcare Inc194.05m10.33m256.22m996.0025.862.207.591.320.25520.25524.793.001.3919.369.51194,824.307.3912.289.1415.5261.1162.575.3210.091.14146.040.05520.0031.8223.2164.631.5033.67--
Nutex Health Inc258.77m-41.00m267.99m800.00--0.4253--1.04-9.18-9.1857.0512.670.620367.704.41323,463.30-8.88-69.35-10.70-84.8515.4910.97-14.32-102.851.630.24890.7617--12.93428.2289.22------
Accolade Inc431.53m-88.99m279.89m2.40k--0.643--0.6486-1.16-1.165.655.520.5253--15.98179,805.00-10.83-24.80-12.43-29.0447.4945.56-20.62-56.43----0.3242--14.0934.3078.29--31.97--
DocGo Inc703.37m21.55m298.60m2.92k14.940.97237.190.42450.19680.19686.553.021.57--3.39241,294.505.47--7.92--32.83--3.49------0.1192--41.72---80.17------
Data as of Jul 05 2024. Currency figures normalised to Airsculpt Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

21.93%Per cent of shares held by top holders
HolderShares% Held
Thrivent Financial for Lutherans (Investment Portfolio)as of 18 Mar 20245.17m8.98%
SW Investment Management LLCas of 31 Mar 20244.29m7.45%
Balyasny Asset Management LPas of 31 Mar 2024879.47k1.53%
BlackRock Fund Advisorsas of 31 Mar 2024665.92k1.16%
The Vanguard Group, Inc.as of 31 Mar 2024554.48k0.96%
Geode Capital Management LLCas of 31 Mar 2024319.74k0.56%
Gilder, Gagnon, Howe & Co. LLCas of 31 Mar 2024238.24k0.41%
SSgA Funds Management, Inc.as of 31 Mar 2024193.92k0.34%
Bandera Partners LLCas of 31 Mar 2024169.21k0.29%
Raymond James Financial Services Advisors, Inc.as of 31 Mar 2024146.12k0.25%
More ▼
Data from 28 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.